Filed: 8/14/2024ACC: 0001214659-24-014472
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 32 equity positions with a total reported market value of $959.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
32
Positions
$959.50M
Total AUM (reported)
80.06M
Total Shares
Allocation by class
COMM$766.24M79.9%
ADRS$193.26M20.1%
Portfolio Concentration
Top 3$289.46M30.2%
4–10$331.35M34.5%
11–25$317.28M33.1%
Rest$21.42M2.2%
Top 3 weight
30.2%
Top 10 weight
64.7%
Voting Authority Distribution
Total shares with voting rights: 80.06M
Sole
Full voting authority
80.06M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole32
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings32
Rows:
CG ONCOLOGY, INC.
SOLEShares3.67M
TypeSH
Market value$115.87M
12.08%
Sole
3.67M
Shared
0.00
None
0.00
DYNE THERAPEUTICS, INC
SOLEShares2.65M
TypeSH
Market value$93.52M
9.75%
Sole
2.65M
Shared
0.00
None
0.00
Abivax SA
SOLEShares6.06M
TypeSH
Market value$80.07M
8.34%
Sole
6.06M
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares3.30M
TypeSH
Market value$62.61M
6.53%
Sole
3.30M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares6.96M
TypeSH
Market value$58.71M
6.12%
Sole
6.96M
Shared
0.00
None
0.00
SAVARA INC.
SOLEShares12.36M
TypeSH
Market value$49.82M
5.19%
Sole
12.36M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares149.28K
TypeSH
Market value$41.82M
4.36%
Sole
149.28K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS, INC.
SOLEShares2.27M
TypeSH
Market value$40.93M
4.27%
Sole
2.27M
Shared
0.00
None
0.00
KEROS THERAPEUTICS, INC.
SOLEShares879.34K
TypeSH
Market value$40.19M
4.19%
Sole
879.34K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS, INC.
SOLEShares3.19M
TypeSH
Market value$37.27M
3.88%
Sole
3.19M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares5.32M
TypeSH
Market value$36.38M
3.79%
Sole
5.32M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$31.81M
3.31%
Sole
1.99M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$29.31M
3.06%
Sole
1.42M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares694.55K
TypeSH
Market value$27.27M
2.84%
Sole
694.55K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.89M
TypeSH
Market value$26.10M
2.72%
Sole
2.89M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS, INC.
SOLEShares2.76M
TypeSH
Market value$25.13M
2.62%
Sole
2.76M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares3.86M
TypeSH
Market value$23.30M
2.43%
Sole
3.86M
Shared
0.00
None
0.00
SOLENO THERAPEUTIVS, INC.
SOLEShares550K
TypeSH
Market value$22.44M
2.34%
Sole
550K
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares486.96K
TypeSH
Market value$21.95M
2.29%
Sole
486.96K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares1.48M
TypeSH
Market value$19.00M
1.98%
Sole
1.48M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS, INC.
SOLEShares556.32K
TypeSH
Market value$15.12M
1.58%
Sole
556.32K
Shared
0.00
None
0.00
ADVERUM BIOTECHNOLOGIES, INC.
SOLEShares2.01M
TypeSH
Market value$13.78M
1.44%
Sole
2.01M
Shared
0.00
None
0.00
VISTAGEN THERAPEUTICS INC
SOLEShares2.68M
TypeSH
Market value$9.31M
0.97%
Sole
2.68M
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares584.96K
TypeSH
Market value$8.34M
0.87%
Sole
584.96K
Shared
0.00
None
0.00
EyePoint Pharmaceuticals, Inc.
SOLEShares922.34K
TypeSH
Market value$8.02M
0.84%
Sole
922.34K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY, INC.SOLE | COMM | 3.67M | SH | $115.87M 12.08% | 3.67M | 0.00 | 0.00 |
DYNE THERAPEUTICS, INCSOLE | COMM | 2.65M | SH | $93.52M 9.75% | 2.65M | 0.00 | 0.00 |
Abivax SASOLE | ADRS | 6.06M | SH | $80.07M 8.34% | 6.06M | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADRS | 3.30M | SH | $62.61M 6.53% | 3.30M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 6.96M | SH | $58.71M 6.12% | 6.96M | 0.00 | 0.00 |
SAVARA INC.SOLE | COMM | 12.36M | SH | $49.82M 5.19% | 12.36M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COMM | 149.28K | SH | $41.82M 4.36% | 149.28K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS, INC.SOLE | COMM | 2.27M | SH | $40.93M 4.27% | 2.27M | 0.00 | 0.00 |
KEROS THERAPEUTICS, INC.SOLE | COMM | 879.34K | SH | $40.19M 4.19% | 879.34K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS, INC.SOLE | COMM | 3.19M | SH | $37.27M 3.88% | 3.19M | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COMM | 5.32M | SH | $36.38M 3.79% | 5.32M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $31.81M 3.31% | 1.99M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $29.31M 3.06% | 1.42M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 694.55K | SH | $27.27M 2.84% | 694.55K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | COMM | 2.89M | SH | $26.10M 2.72% | 2.89M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS, INC.SOLE | COMM | 2.76M | SH | $25.13M 2.62% | 2.76M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | ADRS | 3.86M | SH | $23.30M 2.43% | 3.86M | 0.00 | 0.00 |
SOLENO THERAPEUTIVS, INC.SOLE | COMM | 550K | SH | $22.44M 2.34% | 550K | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | COMM | 486.96K | SH | $21.95M 2.29% | 486.96K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COMM | 1.48M | SH | $19.00M 1.98% | 1.48M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS, INC.SOLE | COMM | 556.32K | SH | $15.12M 1.58% | 556.32K | 0.00 | 0.00 |
ADVERUM BIOTECHNOLOGIES, INC.SOLE | COMM | 2.01M | SH | $13.78M 1.44% | 2.01M | 0.00 | 0.00 |
VISTAGEN THERAPEUTICS INCSOLE | COMM | 2.68M | SH | $9.31M 0.97% | 2.68M | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COMM | 584.96K | SH | $8.34M 0.87% | 584.96K | 0.00 | 0.00 |
EyePoint Pharmaceuticals, Inc.SOLE | COMM | 922.34K | SH | $8.02M 0.84% | 922.34K | 0.00 | 0.00 |
Page 1 of 2